ATLANTA, Dec. 19, 2025 /PRNewswire/ -- UC Asset Limited Partnership (OTCQB: UCASU) today issued a statement applauding President' Trump's decision to rescheduling marijuana from Schedule I to Schedule III, which is a significant measure of deregulation for cannabis industry. UC Asset, which stands for Ultimate Cannabis Asset, is one of the only four US public companies devoted to investing in cannabis properties. Its management claims to have built the "best performing" cannabis property portfolio among US ...

Core Thesis - Tilray Brands, Inc. is positioned for growth through diversification and international expansion, with a focus on cannabis, beverage, and medical products [2][3][6] Financial Performance - Q4 revenue grew 25% year-over-year to $229.9 million, with beverage sales surpassing cannabis revenue for the first time [2] - Q3 2025 results showed revenue of $209.5 million and non-GAAP breakeven EPS, leading to a 22% intraday share price increase [6] Strategic Initiatives - The company acquired four craft breweries from Molson Coors and introduced new cannabis strains in Canada, indicating a commitment to strategic growth [3] - Tilray expanded its medical cannabis programs and obtained new cultivation and trading licenses in Germany, while launching additional products in Portugal and Canada [2] Market and Regulatory Environment - Political developments in 2024, including potential cannabis deregulation under the Trump administration, created speculation around federal reform [3][5] - Despite Florida voters rejecting a legalization amendment, there is sector-wide optimism regarding easing restrictions and potential banking access for cannabis firms [4] Investor Sentiment - A 14% post-market surge in Tilray shares followed signals from the Trump administration regarding potential cannabis reclassification, renewing investor interest [5] - The company is seen as having a compelling risk/reward profile due to a stronger revenue mix, improving balance sheet, and favorable policy sentiment [6]